论文信息 - Pranlukast regulates tumour growth by attenuating IL-4 production in Kimura disease - 字舞流文

Pranlukast regulates tumour growth by attenuating IL-4 production in Kimura disease

Tetsuji Sato | Toshiaki Shimizu | Y. Yamashiro | S. Nagata | T. Fujii | M. Saito | Y. Ohtsuka | Hiroshi Takahashi

[1] T. Shimoda,et al. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen‐specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2] S. Furukawa,et al. Pranlukast inhibits NF‐κB activation in human monocytes/macrophages and T cells , 2003 .

[3] L. J. Woods,et al. Intracrine Cysteinyl Leukotriene Receptor–mediated Signaling of Eosinophil Vesicular Transport–mediated Interleukin-4 Secretion , 2002, The Journal of experimental medicine.

[4] Nakahara,et al. Effects of ONO‐1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.